2 weeks Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates Zacks

Kura Oncology (KURA) delivered earnings and revenue surprises of 65.08% and 76.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?